Effects of vagus nerve stimulation on daily function and quality of life in markedly treatment-resistant major depression: Findings from a one-year, randomized, sham-controlled trial.

Autor: Rush AJ; Duke-NUS Medical School, Singapore; CEO, Curbstone Consultant LLC, Dallas, TX, USA., Conway CR; Department of Psychiatry, Washington University in St Louis, St Louis, MO, USA. Electronic address: conwaycr@wustl.edu., Aaronson ST; Institute for Advanced Diagnostics and Therapeutics, Sheppard Pratt Health System, Baltimore, MD, USA., George MS; Ralph H. Johnson VA Health Care System (VAHCS), Charleston, SC, USA; Medical University of South Carolina, Department of Psychiatry, Charleston, SC, USA., Riva-Posse P; Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Emory University, Atlanta, GA, USA., Dunner DL; Center for Anxiety and Depression, Mercer Island, WA, USA., Zajecka J; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA; Psychiatric Medicine Associates, LLC, Skokie, IL, USA., Bunker MT; LivaNova PLC (or a Subsidiary), London, Great Britain, United Kingdom., Quevedo J; Center for Interventional Psychiatry, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth Houston), Houston, TX, USA., Allen RM; Seattle Neuropsychiatric Treatment Center, Seattle, WA, USA., Alva G; ATP Clinical Research, Costa Mesa, CA, USA., Luing H; Florida Center for TMS, St Augustine, FL, USA., Nahas Z; University of Minnesota, Minneapolis, MN, USA., Manu L; Department of Psychiatry and Behavioral Health, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, USA., Bennett JI; SIU Neuroscience Institute, Springfield, IL, USA., Mickey BJ; Department of Psychiatry, Huntsman Mental Health Institute, University of Utah, Salt Lake City, UT, USA., Becker J; NeuroScience & TMS Treatment Centers, Brentwood, TN, USA., Sheline Y; UPenn Perelman School of Medicine, Philadelphia, PA, USA., Cusin C; Mass General Psychiatry: Depression Clinical & Research Program, Boston, MA, USA., Murrough JW; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Reeves K; The Ohio State University Wexner Medical Center, Columbus, OH, USA., Rosenquist PB; Medical College of Georgia at Augusta University, Augusta, GA, USA., Lee YL; LivaNova PLC (or a Subsidiary), London, Great Britain, United Kingdom., Majewski S; LivaNova PLC (or a Subsidiary), London, Great Britain, United Kingdom., Way J; LivaNova PLC (or a Subsidiary), London, Great Britain, United Kingdom., Olin B; LivaNova PLC (or a Subsidiary), London, Great Britain, United Kingdom., Sackeim HA; Medical University of South Carolina, Department of Psychiatry, Charleston, SC, USA.

Publikováno v: Brain stimulation [Brain Stimul] 2024 Dec 18. Date of Electronic Publication: 2024 Dec 18.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Setting Up a Successful Vagus Nerve Stimulation Service for Patients With Difficult-to-Treat Depression.

Autor: Kraus C; Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria., Quach D; Department of Psychiatry, Washington University in Saint Louis and Barnes Jewish Hospital, St. Louis, MO, USA., Sholtes DM; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA; Capital & Coast District Health Board, Wellington, New Zealand., Kavakbasi E; Department of Psychiatry, University of Münster, Münster, Germany., De Zwaef R; Clinical Affairs, LivaNova Belgium SA, Zaventem, Belgium., Dibué M; Medical Affairs Europe, Neuromodulation, LivaNova Deutschland GmbH (LivaNova PLC owned subsidiary), Munich, Germany., Zajecka J; Department of Psychiatry and Behavioral Sciences, Rush University Medical Center, Chicago, IL, USA., Baune BT; Department of Psychiatry, University of Münster, Münster, Germany; Department of Psychiatry, Melbourne Medical School, University of Melbourne, Melbourne, Australia; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Victoria, Australia. Electronic address: bernhard.baune@ukmuenster.de.

Publikováno v: Neuromodulation : journal of the International Neuromodulation Society [Neuromodulation] 2022 Apr; Vol. 25 (3), pp. 316-326. Date of Electronic Publication: 2022 Feb 02.

Esketamine nasal spray combined with an oral antidepressant for relapse prevention in treatment-resistant depression: results of a double-blind, randomized withdrawal, multicenter study (sustain-1)

Autor: Daly, E.J., Trivedi, M., Janik, A., Li, H., Zhang, Y., Li, X., Lane, R., Duca, A.R., Hough, D., Thase, M.E., Zajecka, J., Winokur, A., Divacka, I., Fagiolini, A., Cubala, W.J., Bitter, I., Blier, P., Shelton, R.C., Molero, P., Manji, H., Drevets, W.C., Singh, J.B.

Publikováno v: In European Neuropsychopharmacology 2019 29 Supplement 1:S92-S92

Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression.

Autor: Fava M; Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114 USA. E-MAIL: mfava@partners.org., Mazzone E, Freeman M, Flynn M, Judge H, Hoeppner B, Hock RS, Shui A, Macaluso M, Morrison MF, Carpenter LL, Shelton R, Zajecka J, Papakostas GI

Publikováno v: Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists [Ann Clin Psychiatry] 2020 Feb; Vol. 32 (4), pp. 18-26.